Facility
The ABF Lab
The location of the ABF Lab will be announced soon. Construction is planned to begin in 2027.
The ABF Lab will combine state-of-the-art research laboratories with long-term cryogenic storage, engineered to support stewardship at scale for generations.
Standby & stabilization
Medical SST presence
ABF-aligned medical standby and stabilization teams support members across major corridors. Coverage today spans the United States and key European hubs.
- San Francisco
- Miami
- New York
- Austin
- Den Haag
- Berlin
- Zurich
At a glance
>2000
Cryo storage capacity: more than two thousand people can be maintained safely at cryogenic temperature at the facility.
2
Cryopreservation service providers partnered at launch.
>20
Concurrent researchers: more than twenty researchers will be able to work in the labs at the facility at the same time.
European partner
European Biostasis Foundation
The European Biostasis Foundation (EBF) is a Switzerland-based foundation dedicated to research and professional, medical-grade biopreservation: protocols, vitrification agents, and long-term stewardship. It operates with a research facility near Zurich and collaborates with institutes across Europe and globally.
EBF and ABF are mission-aligned partners. Either organization can serve as a continuity path for members if long-term storage at one site were ever impractical or unavailable, and the same reciprocity applies in reverse, strengthening resilience for the people who place their trust in us.